Skip to main content

Advertisement

Sudden cardiac death - advances in diagnosis and treatment

Guest Editor: Dr Federico Guerra (Marche Polytechnic University, Ancona, Italy).

Sudden cardiac death is a sudden and unexpected loss of heart function following a sudden cardiac arrest. The chances of surviving a sudden cardiac arrest have improved with advances in fast, resuscitation care. However, it continues to be a major public health challenge. 

Read the below, published content in this thematic series covering all aspects of research into advancing the "Diagnosis and Treatment of Sudden Cardiac Death" ranging from next-generation sequencing methods to eHealth-based intervention protocols.

  1. Content type: Research article

    We aimed to determine the mutation yield and clinical applicability of “molecular autopsy” following sudden arrhythmic death syndrome (SADS) by validating and utilizing low-cost high-throughput technologies: F...

    Authors: Hariharan Raju, James S. Ware, Jonathan R. Skinner, Paula L. Hedley, Gavin Arno, Donald R. Love, Christian van der Werf, Jacob Tfelt-Hansen, Bo Gregers Winkel, Marta C. Cohen, Xinzhong Li, Shibu John, Sanjay Sharma, Steve Jeffery, Arthur A. M. Wilde, Michael Christiansen…

    Citation: BMC Cardiovascular Disorders 2019 19:174

    Published on:

  2. Content type: Research article

    Little is known about the ICD performance using enhanced detection algorithms in unselected, non-trial patients. Performance of recent generation ICD equipped with SmartShock™ technology (SST) for detection an...

    Authors: François Regoli, Denis Graf, Beat Schaer, Firat Duru, Peter Ammann, Lorenza Mangoni di S. Stefano, Barbara Naegli, Haran Burri, Rainer Zbinden, Nazmi Krasniqi and Martin Fromer

    Citation: BMC Cardiovascular Disorders 2019 19:146

    Published on:

  3. Content type: Research article

    Gamma-glutamyltransferase (GGT) is a new predictor of cardiovascular diseases. In this study, we aimed to determine its association with ventricular arrhythmias (VAs) in implantable cardioverter-defibrillator ...

    Authors: You Zhou, Shuang Zhao, Keping Chen, Wei Hua and Shu Zhang

    Citation: BMC Cardiovascular Disorders 2019 19:129

    Published on:

  4. Content type: Case report

    Hypertrophic cardiomyopathy (HCM) is a myocardial disease. However, the coexistence of HCM with muscular ventricular septal defect (VSD), especially those with both incomplete spontaneous closure and coronary ...

    Authors: Guang-mei Zheng, Jiao Bai, Jun-ming Tang, Fang-cheng Zhu and Hong-xia Jing

    Citation: BMC Cardiovascular Disorders 2019 19:16

    Published on:

  5. Content type: Research article

    There are limited data about modes of death and major adverse cardiovascular events (MACEs) in patients with hypertrophic cardiomyopathy (HCM) in South East Asian population. The aim of the study was to examin...

    Authors: Nattakorn Songsirisuk, Veraprapas Kittipibul, Nilubon Methachittiphan, Vorawan Charoenattasil, Nath Zungsontiporn, Ittikorn Spanuchart, Saranya Buppajarntham, Charoen Mankongpaisarnrung, Sudarat Satitthummanid, Suphot Srimahachota, Pairoj Chattranukulchai, Smonporn Boonyaratavej Songmuang and Sarinya Puwanant

    Citation: BMC Cardiovascular Disorders 2019 19:1

    Published on:

  6. Content type: Research article

    Implantable cardioverter defibrillator (ICD) implantation is associated with driving restrictions which may have profound effects on the patient’s life. However, there is limited patient-reported data on the i...

    Authors: Jenny Bjerre, Simone Hofman Rosenkranz, Anne Mielke Christensen, Morten Schou, Christian Jøns, Gunnar Gislason and Anne-Christine Ruwald

    Citation: BMC Cardiovascular Disorders 2018 18:212

    Published on:

  7. Content type: Research article

    Atrial fibrillation (AF) is the most common complication in hypertrophic cardiomyopathy (HCM). The mechanisms of AF is associated with left atrial (LA) structural remodeling in HCM patients. However, the impac...

    Authors: Hongwei Tian, Jingang Cui, Chengzhi Yang, Fenghuan Hu, Jiansong Yuan, Shengwen Liu, Weixian Yang, Xiaowei Jiang and Shubin Qiao

    Citation: BMC Cardiovascular Disorders 2018 18:207

    Published on:

  8. Content type: Study protocol

    In Denmark and other countries, there has been a shift in the management of patients with an implantable cardioverter defibrillator (ICD) with remote device monitoring largely replacing in-hospital visits. Les...

    Authors: Susanne S. Pedersen, Søren J. Skovbakke, Uffe K. Wiil, Thomas Schmidt, Rene dePont Christensen, Carl J. Brandt, Jan Sørensen, Michael Vinther, Charlotte E. Larroudé, Thomas M. Melchior, Sam Riahi, Kim G. E. Smolderen, John A. Spertus, Jens B. Johansen and Jens C. Nielsen

    Citation: BMC Cardiovascular Disorders 2018 18:136

    Published on:

  9. Content type: Research article

    Transmural acute myocardial infarction (AMI) is associated with a high risk for ventricular arrhythmia before, during and after treatment. Consequently, it is recommended that patients diagnosed with transmura...

    Authors: Marco Albanese, Korhan Alpaslan, Taoufik Ouarrak, Peter Merguet, Steffen Schneider and Wolfgang Schöls

    Citation: BMC Cardiovascular Disorders 2018 18:116

    Published on:

  10. Content type: Research article

    The wearable cardioverter-defibrillator (WCD) has emerged as a valuable tool to temporarily protect patients at risk for sudden cardiac death (SCD). The aim of this study was to determine the value of the WCD ...

    Authors: Susanne Röger, Stefanie L. Rosenkaimer, Anna Hohneck, Siegfried Lang, Ibrahim El-Battrawy, Boris Rudic, Erol Tülümen, Ksenija Stach, Jürgen Kuschyk, Ibrahim Akin and Martin Borggrefe

    Citation: BMC Cardiovascular Disorders 2018 18:52

    Published on: